Viewing Study NCT01943851


Ignite Creation Date: 2025-12-24 @ 11:49 PM
Ignite Modification Date: 2025-12-25 @ 9:43 PM
Study NCT ID: NCT01943851
Status: COMPLETED
Last Update Posted: 2024-10-01
First Post: 2013-09-12
Is NOT Gene Therapy: False
Has Adverse Events: True

Brief Title: A Dose Escalation Study to Investigate the Safety, Pharmacokinetics (PK), Pharmacodynamics (PD) and Clinical Activity of GSK525762 in Subjects With Relapsed, Refractory Hematologic Malignancies
Sponsor: GlaxoSmithKline
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-05-14
Start Date Type: ACTUAL
Primary Completion Date: 2020-04-30
Primary Completion Date Type: ACTUAL
Completion Date: 2020-04-30
Completion Date Type: ACTUAL
First Submit Date: 2013-09-12
First Submit QC Date: None
Study First Post Date: 2013-09-17
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2021-04-26
Results First Submit QC Date: None
Results First Post Date: 2021-05-19
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-09-06
Last Update Post Date: 2024-10-01
Last Update Post Date Type: ACTUAL